AsiaMedic Limited (505) Fair Value & Analysis
Healthcare · SG · Market cap 26.4M SGD
Fair value as of: Jul 4, 2026
From 24 valuation models · updated today
Price vs Fair Value (12 months)
12‑month range 0.0120 SGD – 0.0270 SGD · fair‑value band 0.0223 SGD – 0.0269 SGD · the 0.0230 SGD price screens below the 0.0246 SGD fair value. As of Jul 4, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
AsiaMedic Limited (505) currently trades at 0.0230 SGD, while our model-based Fair Value estimate is 0.0246 SGD — implying the stock looks roughly 7.0% undervalued today. We read business quality at 62/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, AsiaMedic Limited generated revenue of 35.3M SGD at a net margin of 5.7%. Revenue grew 17.7% year over year. It earns a return on equity of 8.2%. Fundamentals as of Jul 4, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 4, 2026. TTM = trailing twelve months.
About the company
AsiaMedic Limited provides healthcare services in Singapore. It offers diagnostic imaging and radiology services, such as magnetic resonance imaging, computed tomography, bone densitometry, ultrasound, mammography, and x-ray imaging services, as well as cardiovascular, musculoskeletal, ear, nose and throat, breast, body, and neuroradiology assessments to general practitioners, specialists, and hospitals; and positron emission tomography and computed tomography scans for cardiac and cancer imaging. The company also provides primary healthcare services; medical aesthetic services, including laser skin rejuvenation, non-surgical facelifts, dermal fillers, body contouring, and skincare solutions; medical arrangement, travel medical concierge, diagnostic scan, wellness, medical evacuation, and visa services; and pharmaceuticals and aesthetic products. In addition, it operates family clinics and a boutique aesthetic clinic. The company was incorporated in 1974 and is based in Singapore.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
AsiaMedic Limited reported revenue of 35.2M SGD in FY2025 versus 18.3M SGD in FY2021, a compound +17.9%/yr. Reported net income was 2.0M SGD in FY2025, compounding +29.7%/yr from FY2021.
Is 505 fairly valued? → Check now
Similar stocks
6 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | $482.04 | $202.02 | -58% |
| Danaher Corporation DHR | $183.63 | $87.65 | -52% |
| WuXi AppTec Co 2359 | HK$152.80 | HK$120.99 | -21% |
| IDEXX Laboratories, Inc IDXX | $545.73 | $255.77 | -53% |
| Lonza Group LZAGY | $61.53 | $15.70 | -74% |
| Agilent Technologies, Inc A | $126.67 | $63.09 | -50% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is AsiaMedic Limited (505) undervalued?
What is the fair value of 505?
What is the quality score of 505?
What is the revenue of AsiaMedic Limited (505)?
What is the net profit margin of 505?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.